Susquehanna Fundamental Investments, LLC Igm Biosciences, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $2.14 Trillion
- Q1 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 27,731 shares of IGMS stock, worth $174,150. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,731Holding current value
$174,150% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
89Shares Held
20.5MCall Options Held
11.1KPut Options Held
5.1K-
Baker Bros. Advisors LP New York, NY4.09MShares$25.7 Million0.5% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.89MShares$24.4 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N43.08MShares$19.3 Million1.6% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$19.3 Million1.17% of portfolio
-
Goldman Sachs Group Inc New York, NY1.28MShares$8.03 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $182M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...